221 related articles for article (PubMed ID: 31971609)
1. Perfecting a high hypoxanthine phosphoribosyltransferase activity-uricase KO mice to test the effects of purine- and non-purine-type xanthine dehydrogenase (XDH) inhibitors.
Hosoya T; Uchida S; Shibata S; Tomioka NH; Hosoyamada M
Br J Pharmacol; 2020 May; 177(10):2274-2285. PubMed ID: 31971609
[TBL] [Abstract][Full Text] [Related]
2. Xanthine Oxidoreductase Inhibitors Suppress the Onset of Exercise-Induced AKI in High HPRT Activity
Hosoya T; Uchida S; Shibata S; Tomioka NH; Matsumoto K; Hosoyamada M
J Am Soc Nephrol; 2022 Feb; 33(2):326-341. PubMed ID: 34799437
[TBL] [Abstract][Full Text] [Related]
3. The Mechanism of False in Vitro Elevation of Uric Acid Level in Mouse Blood.
Watanabe T; Tomioka NH; Watanabe S; Suzuki Y; Tsuchiya M; Hosoyamada M
Biol Pharm Bull; 2016 Jul; 39(7):1081-4. PubMed ID: 27170514
[TBL] [Abstract][Full Text] [Related]
4. Xanthine oxidoreductase knockout mice with high HPRT activity were not rescued by NAD
Hosoyamada M; Tomioka NH; Ohtsubo T; Ichida K
Nucleosides Nucleotides Nucleic Acids; 2020; 39(10-12):1465-1473. PubMed ID: 32126884
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of allopurinol in patients with hypoxanthine-guanine phosphoribosyltransferase deficiency.
Torres RJ; Prior C; Puig JG
Metabolism; 2007 Sep; 56(9):1179-86. PubMed ID: 17697859
[TBL] [Abstract][Full Text] [Related]
6. Urat1-Uox double knockout mice are experimental animal models of renal hypouricemia and exercise-induced acute kidney injury.
Hosoyamada M; Tsurumi Y; Hirano H; Tomioka NH; Sekine Y; Morisaki T; Uchida S
Nucleosides Nucleotides Nucleic Acids; 2016 Dec; 35(10-12):543-549. PubMed ID: 27906636
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of allopurinol in patients with the Lesch-Nyhan syndrome and partial hypoxanthine- phosphoribosyltransferase deficiency: a follow-up study of 18 Spanish patients.
Torres RJ; Prior C; Puig JG
Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1077-82. PubMed ID: 17065067
[TBL] [Abstract][Full Text] [Related]
8. The renal phenotype of allopurinol-treated HPRT-deficient mouse.
Zennaro C; Tonon F; Zarattini P; Clai M; Corbelli A; Carraro M; Marchetti M; Ronda L; Paredi G; Rastaldi MP; Percudani R
PLoS One; 2017; 12(3):e0173512. PubMed ID: 28282408
[TBL] [Abstract][Full Text] [Related]
9. Purine metabolism in female heterozygotes for hypoxanthine-guanine phosphoribosyltransferase deficiency.
Puig JG; Mateos FA; Torres RJ; Buño AS
Eur J Clin Invest; 1998 Nov; 28(11):950-7. PubMed ID: 9824441
[TBL] [Abstract][Full Text] [Related]
10. Inhibiting PNP for the therapy of hyperuricemia in Lesch-Nyhan disease: Preliminary in vitro studies with analogues of immucillin-G.
Jacomelli G; Baldini E; Mugnaini C; Micheli V; Bernardini G; Santucci A
J Inherit Metab Dis; 2019 Jan; 42(1):178-185. PubMed ID: 30740729
[TBL] [Abstract][Full Text] [Related]
11. Uricosuric agents decrease the plasma urate level in rats by concomitant treatment with topiroxostat, a novel xanthine oxidoreductase inhibitor.
Taniguchi T; Ashizawa N; Matsumoto K; Iwanaga T; Saitoh K
J Pharm Pharmacol; 2016 Jan; 68(1):76-83. PubMed ID: 26589240
[TBL] [Abstract][Full Text] [Related]
12. Gout, uric acid and purine metabolism in paediatric nephrology.
Cameron JS; Moro F; Simmonds HA
Pediatr Nephrol; 1993 Feb; 7(1):105-18. PubMed ID: 8439471
[TBL] [Abstract][Full Text] [Related]
13. [Purine transport through the blood-brain barrier in hypoxanthine phosphoribosyltransferase deficiency].
López Jiménez M; García Puig J; Mateos Antón F; Ramos Hernández T; Pascual Castroviejo I; Ortiz Vázquez J
Med Clin (Barc); 1989 Feb; 92(5):167-70. PubMed ID: 2725104
[TBL] [Abstract][Full Text] [Related]
14. Effects of allopurinol on beer-induced increases in plasma concentrations and urinary excretion of purine bases (uric acid, hypoxanthine, and xanthine).
Ka T; Moriwaki Y; Inokuchi T; Yamamoto A; Takahashi S; Tsutsumi Z; Yamamoto T
Horm Metab Res; 2006 Mar; 38(3):188-92. PubMed ID: 16673211
[TBL] [Abstract][Full Text] [Related]
15. Lesch-Nyhan syndrome and its pathogenesis: purine concentrations in plasma and urine with metabolite profiles in CSF.
Harkness RA; McCreanor GM; Watts RW
J Inherit Metab Dis; 1988; 11(3):239-52. PubMed ID: 3148065
[TBL] [Abstract][Full Text] [Related]
16. Comparison of topiroxostat and allopurinol in Japanese hyperuricemic patients with or without gout: a phase 3, multicentre, randomized, double-blind, double-dummy, active-controlled, parallel-group study.
Hosoya T; Ogawa Y; Hashimoto H; Ohashi T; Sakamoto R
J Clin Pharm Ther; 2016 Jun; 41(3):290-7. PubMed ID: 27109450
[TBL] [Abstract][Full Text] [Related]
17. Purine metabolism in women with primary gout.
Puig JG; Mateos FA; Miranda ME; Torres RJ; de Miguel E; Pérez de Ayala C; Gil AA
Am J Med; 1994 Oct; 97(4):332-8. PubMed ID: 7942934
[TBL] [Abstract][Full Text] [Related]
18. Effects of topiroxostat and febuxostat on urinary albumin excretion and plasma xanthine oxidoreductase activity in db/db mice.
Nakamura T; Murase T; Nampei M; Morimoto N; Ashizawa N; Iwanaga T; Sakamoto R
Eur J Pharmacol; 2016 Jun; 780():224-31. PubMed ID: 27038523
[TBL] [Abstract][Full Text] [Related]
19. The effect of nutritional state and allopurinol on nucleotide formation in enterocytes from the guinea pig small intestine.
Gross CJ; Savaiano DA
Biochim Biophys Acta; 1991 Mar; 1073(2):260-7. PubMed ID: 2009279
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of excessive purine biosynthesis in hypoxanthine-guanine phosphoribosyltransferase deficiency.
Sorensen LB
J Clin Invest; 1970 May; 49(5):968-78. PubMed ID: 5441549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
